Considering a molecular laboratory viewpoint, Relafen 750 (Naproxen) exhibits particular behaviors. It works primarily as a non-copyrightal agent, selectively blocking cyclooxygenase-2 (COX-2), an protein implicated in prostaglandin synthesis . This targeted inhibition results in diminished inflammation and discomfort , offering therapeutic advanta